Site: |
Fox Chase Cancer Center |
|||
Address: |
333 Cottman Ave |
|||
City: |
Philadelphia |
|||
State: |
PA |
|||
Zip: |
19111 |
|||
Country: |
USA |
2 |
Terminated |
Closed |
Nilotinib and Imatinib |
NCT01089595 |
|
2 |
Completed |
Closed |
STA-9090 |
NCT01039519 |
|
2 |
Ongoing, but not recruiting |
Closed |
Regorafenib (BAY 73-4506) |
NCT01068769 |
|
2 |
Completed |
Closed |
Crenolanib (CP-868,596) |
NCT01243346 |
|
2 |
Completed |
Closed |
Imatinib + RAD001 |
NCT01275222 |
|
2 |
Completed |
Closed |
Imatinib + AT13387 |
NCT01294202 |
|
2 |
Completed |
Closed |
Linsitinib (OSI-906) |
NCT01560260 |
|
2 |
Completed |
Closed |
Ponatinib (Iclusig) |
NCT01874665 |
|
1 |
Ongoing, but not recruiting |
Closed |
Sunitinib + CP-751,871 |
NCT00729833 |
|
1 |
Withdrawn |
Closed |
CS-1008 and Imatinib or Sunitinib |
||
1 |
Completed |
Closed |
Imatinib and Nilotinib |
NCT00135005 |
|
1 |
Ongoing, but not recruiting |
Closed |
BIIB022 |
NCT00555724 |
|
1 |
Ongoing, but not recruiting |
Closed |
PLX3397 (PLX108-01) |
NCT01004861 |
|
1 |
Active, not recruiting |
Closed |
BLU-285 |
NCT02508532 |
|
1 |
Active, not recruiting |
Closed |
QINLOCK
Ripretinib
DCC-2618 |
NCT02571036 |
|
2 |
Not yet recruiting |
Not yet activated |
Bezuclastinib plus Sunitinib |
NCT06208748 |